BindingDB Data by Journal




PMID
Data
Article Title
Citation
Organization
Download Data
P-glycoprotein inhibition by the multidrug resistance-reversing agent MS-209 enhances bioavailability and antitumor efficacy of orally administered paclitaxel.EBI
Cancer Chemother Pharmacol 49: 322-8 (2002)
Nihon Schering K.K.